# Amundi Index Solutions - MSCI Europe UCITS ETF DR (CE2D)

**Source:** https://fundology.uk/fund/ce2d · ISIN LU1737652310 · Data: TradingView (LSE closes and returns, delayed), issuer documents, ONS CPIH, FCA FIRDS

## At a glance

> Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.

As of 30/09/2026, CE2D (Amundi Index Solutions - MSCI Europe UCITS ETF DR, ISIN LU1737652310) closed at £69.99 on the London Stock Exchange. Its ongoing charge is 0.20% a year (about £20 on £10,000). Over the five years to 30/09/2026 its total return was +63.1%, or +27.5% after UK CPIH inflation.

## Summary

Amundi Index Solutions - MSCI Europe UCITS ETF DR is an exchange-traded fund (ETF) from Amundi, launched in 2017. It tracks the MSCI Europe Index - EUR - Benchmark TR Net — large and medium-sized European companies. You buy and sell it through a share-dealing account or platform during stock-market hours, like a share. Its ongoing charge is 0.2% a year — about £20 a year on every £10,000 invested, taken from the fund's value rather than billed to you. Income from its investments is paid out to holders as cash, usually a few times a year.

Latest close: **£69.99** (30/09/2026).

## Key facts

| Fact | Value |
|---|---|
| Ticker (LSE) | CE2D |
| ISIN | LU1737652310 |
| Category | European shares |
| Type | ETF |
| Provider | Amundi |
| Tracks | MSCI Europe Index - EUR - Benchmark TR Net |
| Income | Distributing |
| Ongoing charge | 0.20% a year (£20 per £10,000) |
| Fund size | £299m |
| Launched | 2017 |
| Domicile | Luxembourg |

## Past returns (periods to 30/09/2026)

After the fund's ongoing charges. "Income reinvested" is total return; "price only" leaves out income paid out. Real returns are after ONS CPIH inflation.

| Window | Return | After CPIH inflation | Measured as |
|---|---|---|---|
| 1 year | +15.80% | +12.16% | income reinvested |
| 3 years | +51.47% | +36.68% | income reinvested |
| 5 years | +63.07% | +27.48% | income reinvested |

Returns: TradingView (delayed data). Inflation: ONS CPIH, latest month published.

## Calendar-year returns

Calendar-year returns of Amundi Index Solutions - MSCI Europe UCITS ETF DR in pounds (price only, income paid out not included): 2022 −6.4%, 2023 +10.1%, 2024 +0.8%, 2025 +22.3%; 2026 to 30/09/2026 +8.4%. Returns of Amundi Index Solutions - MSCI Europe UCITS ETF DR in pounds (price only, income paid out not included) over the 12 months to 30/09/2026: +12.5%; to 30/09/2025: +9.6%; to 30/09/2024: +12.3%; to 30/09/2023: +14.7%; to 30/09/2022: −12.0%.

| Year | Return | After CPIH inflation | Measured as |
|---|---|---|---|
| 2022 | -6.4% | -14.3% | Price |
| 2023 | +10.1% | +5.7% | Price |
| 2024 | +0.8% | -2.6% | Price |
| 2025 | +22.3% | +18.1% | Price |
| 2026 to 30/09/2026 | +8.4% | +5.4% | Price |

## Risk metrics

| Window | Volatility | Max drawdown |
|---|---|---|
| 1 year | 13.05% | -10.48% |
| 3 years | 12.26% | -10.48% |
| 5 years | 13.59% | -16.73% |

## Largest fall

Volatility of Amundi Index Solutions - MSCI Europe UCITS ETF DR in pounds, annualised from weekly returns to 30/09/2026: 13.0% over 1 year, 12.3% over 3 years, 13.6% over 5 years. Largest fall in the price of Amundi Index Solutions - MSCI Europe UCITS ETF DR since October 2021, in pounds: −16.7% from 12/11/2021 to 04/03/2022. The lowest 12-month return of Amundi Index Solutions - MSCI Europe UCITS ETF DR in pounds (price only, income paid out not included) since January 2021 was −11.9% (12 months to 14/10/2022); the highest was +26.5% (12 months to 10/04/2026). On 30/09/2026 the price of Amundi Index Solutions - MSCI Europe UCITS ETF DR was 3.5% below its highest weekly close since October 2021 (06/08/2026), in pounds.

## Charges compared with similar funds

Ongoing charge of Amundi Index Solutions - MSCI Europe UCITS ETF DR 0.20% a year, as of 01/10/2026: 120 of the 225 other European share funds charge more, 19 the same and 86 less (share classes counted once).

## Funds tracking the same index

18 funds track MSCI Europe Index - EUR - Benchmark TR Net, this one included and share classes counted once; their ongoing charges range from 0.10% to 0.31% a year (30/09/2026).

| Fund | Ongoing charge | 1 year | 3 years | 5 years |
|---|---|---|---|---|
| Amundi Index Solutions - MSCI Europe UCITS ETF DR | 0.15% | +15.8% | +51.5% | +63.1% |
| Amundi Index Solutions - MSCI Europe UCITS ETF DR (this fund) | 0.20% | +15.8% | +51.5% | +63.1% |
| Amundi MSCI Europe UCITS ETF Act -Acc- | 0.25% | +15.8% | +51.0% | +62.2% |
| BNP PARIBAS EASY MSCI EUROPE ETF Capitalisation -UCITS ETF- | — | — | — | — |
| Deka MSCI Europe UCITS ETF | 0.30% | +15.3% | +50.9% | +56.3% |
| HSBC MSCI Europe UCITS ETF Accum EUR | 0.14% | +15.7% | +36.9% | — |
| HSBC MSCI Europe UCITS ETF EUR | 0.14% | +15.7% | +51.5% | +63.2% |
| Invesco MSCI Europe UCITS ETF | 0.19% | +15.7% | +47.4% | +60.5% |
| iShares Core MSCI Europe UCITS ETF | 0.12% | +15.8% | +51.6% | +63.4% |
| iShares Core MSCI Europe UCITS ETF Accum Shs Hedged MXN | 0.17% | — | — | — |
| iShares Core MSCI Europe UCITS ETF EUR (Acc) | 0.12% | +15.8% | +51.6% | +63.3% |
| State Street SPDR MSCI Europe UCITS ETF | 0.25% | +15.7% | +51.2% | +62.4% |
| UBS (Lux) Fund Solutions SICAV - UBS Core MSCI Europe UCITS ETF EUR dis- Distribution | 0.10% | +15.9% | +51.8% | +63.2% |
| UBS Core MSCI Europe UCITS ETF Capitalisation -USD- | — | — | — | — |
| UBS Core MSCI Europe UCITS ETF Capitalisation A | 0.10% | +8.8% | — | — |
| Xtrackers MSCI EUROPE UCITS ETF Capitalisation 1C | 0.13% | +15.7% | +51.3% | +63.3% |
| Xtrackers MSCI EUROPE UCITS ETF Capitalisation 2C | 0.31% | +21.0% | +47.9% | +80.5% |
| Xtrackers MSCI EUROPE UCITS ETF Distribution 1D | 0.13% | +15.3% | +51.1% | +63.1% |

Returns are the data vendor’s, in pounds, income reinvested unless marked "(price)".

## Charges & eligibility

- Ongoing charges figure (OCF): **0.20%** per year
- ISA eligible: yes
- SIPP eligible: yes

## Top holdings

Largest positions (as of 29/09/2026):

| Holding | Weight |
|---|---|
| ASML | 5.09% |
| HSBC | 2.48% |
| Roche | 2.13% |
| Shell | 1.99% |
| Novartis Ag-Reg | 1.92% |
| AstraZeneca | 1.79% |
| Nestle Sa-Reg | 1.70% |
| Siemens Ag-Reg | 1.67% |
| SAP SE / Xetra | 1.54% |
| Banco Santander SA Madrid | 1.46% |

## Where it invests

Shares of the whole fund. Bonds, cash and positions the source does not classify are shown as they come, not guessed.

### By sector

As published by Amundi, as of 29/09/2026.

| Sector | Weight |
|---|---|
| Financials | 25.6% |
| Industrials | 18.7% |
| Health Care | 12.7% |
| Information Technology | 9.7% |
| Consumer Staples | 8.2% |
| Consumer Discretionary | 6.0% |
| Materials | 5.4% |
| Energy | 5.4% |
| Other sectors | 8.4% |

### By country

As published by Amundi, as of 29/09/2026.

| Country | Weight |
|---|---|
| United Kingdom | 22.4% |
| France | 14.8% |
| Switzerland | 14.2% |
| Germany | 13.7% |
| Netherlands | 9.4% |
| Spain | 6.3% |
| Sweden | 5.3% |
| Italy | 5.2% |
| Other countries | 8.7% |

All 397 holdings: https://fundology.uk/fund/ce2d/holdings

---

We show information. We are not financial advisers, not authorised by the FCA, and never recommend specific investments.

Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.
